The reduction in price target by RBC Capital could have a mixed impact on QuidelOrtho's stock price. While the Outperform rating reaffirms a positive outlook, the lowered price target may signal a tempered expectation for the stock's growth potential. Investors may react to the new price target, but the reaffirmation of the Outperform rating could balance out any negative sentiment.